VALERIE BREEDING: Open Payments
NPI 1427508738 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 94 payments from 25 companies in 2025. Trend: 2023 $827 · 2024 $1,332 · 2025 $1,701
Food & beverage: $1,701
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $267 |
| ABBVIE INC. | 18 | $232 |
| AstraZeneca Pharmaceuticals LP | 8 | $196 |
| Novo Nordisk Inc | 9 | $146 |
| Axsome Therapeutics, Inc. | 4 | $116 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $64 |
| Amgen Inc. | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
Products named: VRAYLAR, MOUNJARO, Auvelity, BREZTRI, AIRSUPRA, VOQUEZNA, Wegovy, Ozempic.
Industry payments across KY — which companies pay providers there.
